{
    "2018-06-01": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Imerys unit settles talc claims for at least $5 million: Bloomberg",
                "features": {
                    "keywords": [
                        "Imerys",
                        "talc",
                        "claims",
                        "settle"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "materials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "ITOT, JPM, XOM, JNJ: Large Inflows Detected at ETF",
                "features": {
                    "keywords": [
                        "ETF",
                        "inflows",
                        "JNJ",
                        "JPM",
                        "XOM"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "energy",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How JNJ Is Positioned to Achieve Growth in the Orthopedics Space",
                "features": {
                    "keywords": [
                        "JNJ",
                        "growth",
                        "orthopedics"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson’s Over-the-Counter Growth through Innovation",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "OTC",
                        "innovation",
                        "growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Imerys Unit Said to Settle Talc Claims for at Least $5 Million",
                "features": {
                    "keywords": [
                        "Imerys",
                        "talc",
                        "settle",
                        "claims"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "materials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Discussing JNJ’s Strategy for Advancing Stroke Treatments",
                "features": {
                    "keywords": [
                        "JNJ",
                        "stroke",
                        "treatment",
                        "strategy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Johnson & Johnson Is Driving Growth for Beauty Products",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "beauty",
                        "growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson Is Reinventing Its Oral Care Franchise",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "oral care",
                        "reinvent"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Breakfast Technical Briefing on Johnson & Johnson and Three Other Additional Healthcare Stocks",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "technical briefing",
                        "healthcare"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "[$$] Big Pharma on mission to bring immunotherapy to more patients",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "immunotherapy",
                        "patients"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Celgene Appoints J&J's David Elkins As EVP, CFO, Succeeding Peter Kellogg",
                "features": {
                    "keywords": [
                        "Celgene",
                        "J&J",
                        "David Elkins",
                        "EVP",
                        "CFO"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}